Technopath Clinical Diagnostics

Acquired By LGC
Quality control materials and informatics solutions for clinical diagnostics.

About Technopath Clinical Diagnostics

Technopath Clinical Diagnostics is a Healthcare company, and was acquired by LGC in February 2021. Quality control materials and informatics solutions for clinical diagnostics. It operates on a B2B and B2C model. Technopath Clinical Diagnostics offers products and services including Multichem QC and IAMQC Solutions. Its focus areas include Informatics, Software Solutions, Peer Reporting Systems and Clinical Diagnostics.

Company details

Technopath Clinical Diagnostics is identified as a global developer and manufacturer of quality control materials and software, primarily serving clinical laboratories. Products such as Multichem QC and IAMQC solutions are supplied to enhance laboratory efficiencies in areas like immunoassay and infectious disease testing. Partnerships with entities including Abbott and Northwell Health have been formed to distribute these solutions. Resources, including webinars and educational materials, are made available through the Knowledge Centre. Operations are conducted from locations in Ireland and the USA, focusing on meeting regulatory standards in diagnostics.

  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website technopathclinicaldiagnostics.com
  • Social LinkedIn
  • Acquired by LGC (Feb 2021)
  • Legal Name Technopath Clinical Diagnostics
Key Metrics

Products & Services of Technopath Clinical Diagnostics

Technopath Clinical Diagnostics offers a comprehensive portfolio of products and services, including Multichem QC and IAMQC Solutions.

Multichem QC
Quality Control Materials

Quality control materials are supplied for various diagnostic tests, including high-sensitive troponin QC in a frozen liquid stable format

IAMQC Solutions
Informatics Solutions

Software solutions are offered for peer reporting and quality control management in clinical laboratories

Funding Insights of Technopath Clinical Diagnostics

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Technopath Clinical Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2018Debt – Conventional––
Valuation history

2 investors in total: 2 institutional.

Investors in Technopath Clinical Diagnostics

Technopath Clinical Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LGC and Proventus.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
A family office is operated across Nordic and European regions.
proventus.seStockholm, Sweden
Molecular biology reagents and services are supplied to biotech industries.
1842lgcgroup.comTeddington, United Kingdom
Premium access

Investor details for Technopath Clinical Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Technopath Clinical Diagnostics

2 dated milestones of Technopath Clinical Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round.
  2. Exit Acquired by LGC.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Technopath Clinical Diagnostics

Technopath Clinical Diagnostics is identified as a global developer and manufacturer of quality control materials and software, primarily serving clinical laboratories. Products such as Multichem QC and IAMQC solutions are supplied to enhance laboratory efficiencies in areas like immunoassay and infectious disease testing. Partnerships with entities including Abbott and Northwell Health have been formed to distribute these solutions. Resources, including webinars and educational materials, are made available through the Knowledge Centre. Operations are conducted from locations in Ireland and the USA, focusing on meeting regulatory standards in diagnostics.

Technopath Clinical Diagnostics offers Multichem QC and IAMQC Solutions.

Technopath Clinical Diagnostics has 2 investors. Key investors include LGC, and Proventus.

Technopath Clinical Diagnostics operates through Technopath Clinical Diagnostics.

Yes. Technopath Clinical Diagnostics was acquired by LGC in February 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available